图书馆订阅: Guest
Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集
环境病理学,毒理学和肿瘤学期刊
影响因子: 1.241 5年影响因子: 1.349 SJR: 0.519 SNIP: 0.613 CiteScore™: 1.61

ISSN 打印: 0731-8898
ISSN 在线: 2162-6537

环境病理学,毒理学和肿瘤学期刊

DOI: 10.1615/JEnvironPatholToxicolOncol.2017019366
pages 99-105

Regulating RNA Binding Motif 5 Gene Expression− A Novel Therapeutic Target for Lung Cancer

Venugopal Vinod Prabhu
Department of Biochemistry, University of Madras, Guindy campus, Chennai−600025, Tamil Nadu, India
Niranjali Devaraj
Department of Biochemistry, University of Madras, Guindy campus, Chennai−600025, Tamil Nadu, India

ABSTRACT

RNA-binding motif protein 5 (RBM5), also known as LUCA-15/H37, is a gene that maps to human chromosome 3p21.3, a critical region that is deleted in a large number of human cancers, of which the majority are lung cancers, and that is predicted to contain one or more tumor suppressor genes (TSGs). RBM5 is a tumor suppressor gene and is most frequently deleted at the earliest stage of lung cancer development. It represents a significant area of recent progress in cancer genomic, cytogenetic, and molecular biological research because of its role in the induction of cell cycle arrest and apoptosis and the regulation of inhibition of in lung cancer metastasis. RBM5 is involved in the suppression of epidermal growth factor receptor (EGFR) expression, thus preventing proliferation, angiogenesis, invasion, and metastasis of lung cancer. In this way it exhibits its tumor suppressive capacity during lung cancer progression. Exploration of RBM5's potential importance in inhibiting tumor metastasis includes downstream players in the RBM5-mediated metastasis suppressor pathway(s). This review highlights the differential expression of the RBM5 tumor suppressor gene which impacts cell proliferation and apoptosis control during lung cancer progression. Regulating RBM5 expression may be a novel therapeutic target for lung cancer.


Articles with similar content:

RKIP-1 and the Cell Cycle: Novel Insight Into Genomic Instability
Forum on Immunopathological Diseases and Therapeutics, Vol.2, 2011, issue 1
Fahd Al-Mulla
Epigenetic Control of Tumor Suppression
Critical Reviews™ in Eukaryotic Gene Expression, Vol.17, 2007, issue 4
Keith D. Robertson, Stela S. Palii
Neuroendocrine Cells in Prostate Cancer
Critical Reviews™ in Eukaryotic Gene Expression, Vol.14, 2004, issue 4
Sarah J. Parsons, George P. Amorino
Induction of RKIP Expression by Anticancer Therapeutic Antibodies and Its Role in the Reversal of Chemo- and Immunoresistance
Forum on Immunopathological Diseases and Therapeutics, Vol.2, 2011, issue 2
Benjamin Bonavida
Molecular Mechanisms Underlying the Role of MicroRNAs in Resistance to Epidermal Growth Factor Receptor-Targeted Agents and Novel Therapeutic Strategies for Treatment of Non-Small-Cell Lung Cancer
Critical Reviews™ in Oncogenesis, Vol.18, 2013, issue 4
Elena Galvani, Godefridus J. Peters, Mina Maftouh, Elisa Giovannetti, Amir Avan